Who is Responsible for Remdesivir?

by W.A. Eliot American Thinker

No doubt many of you are tired of discussing remdesivir. But there are two reasons to continue doing so:

1) remdesivir is still on the COVID inpatient hospital protocol, and

2) no one has been held responsible for it.

Here I’m going to focus on responsibility, for which I’ll have to spread the wealth:

Gilead Sciences, Inc. It knew about its drug’s toxicity, but money apparently is all that mattered.